🚀 The team led by our CEO, Lance H., along with Scientific Account Manager John Merritt and R&D Director Dr. Shun Zhou, successfully completed a Lunch & Learn Seminar at Ionis Pharmaceuticals, Inc., focused on our HUGO-GT program. It was a fantastic session, and we had the pleasure of meeting so many talented minds in the field. We're excited for the upcoming seminars and the continued collaboration! Learn more about the HUGO-GT here: https://lnkd.in/gdNF9Cbf #Biotech #Innovation #HUGOGT #Networking #Research #HUGUS #Innovation #LifeSciences #Collaboration #Seminars
Cyagen’s Post
More Relevant Posts
-
CEO Vir Biotechnology, Inc. Board Member. Passionate about making a difference for patients.
In my conversation with Fraiser Kansteiner and Fierce Pharma at #FierceJPMWeek I plan to share more information about strategic decisions made in my first year as CEO of Vir Biotechnology, Inc., including expanding our focus and harnessing the power of our proven antibody platform into additional areas including viral-associated and immune-mediated diseases. With the progress already made in our #HDV and #HBV clinical programs, we are well positioned to leverage Vir’s in-house immunology and virology expertise to help transform the lives of millions of patients worldwide. #Patientsarewaiting
Join Marianne D. De Backer, MSc, PhD, MBA, Chief Executive Officer, Vir Biotechnology, Inc., and over 500 senior pharma and biotech executives at Fierce JPM Week on Jan 9-10th. Dr. De Backer will sit with the Fierce Editorial Team for an exclusive executive interview on Wednesday, Jan 10th. Register Now! ➡ https://ow.ly/OB2050Qlv10 Check out the all-star lineup of speakers already confirmed! https://ow.ly/70Hq50Q86RO #FierceJPMWeek #WeAreFierce #FierceBiotech #FiercePharma #JPMWeek #Pharma #Biotech
-
-
In the latest episode of "Conversations Life Science Leaders Aren't Having" with Jeff Harmon, Rob Etherington, CEO of Clene Nanomedicine, Inc. shares his perspective on valuations in #BioTech and #Pharma. After the 2024 JPMorgan Healthcare Conference, he addresses the challenging market conditions and their impact on investor confidence. Etherington highlights the enduring importance of pharmaceutical innovation in a challenging investment market. This insightful discussion is a must-watch for industry professionals seeking to navigate these complex times. #HealthcareConference #InvestorConfidence #LifeSciences #JPM2024
-
Not being the tallest myself, I've always held a special place in my heart for the beauty of small things. This might be why Fragment-Based Drug Discovery (FBDD 😍 ) resonates so strongly with me! I'm thrilled to share that Selvita's Project Owner, Aleksandra Bebel, will be participating in the upcoming 9thRSC-BMCS (https://bit.ly/49NNavX). Selvita has a number of exciting FBDD projects where Aleksandra played a key role in X-ray screening of fragments, with my skilled team supporting them with CADD. Our main tools for this work are InfiniSee and SeeSAR (thanks Marcus Gastreich, BioSolveIT), and we're also grateful for the strong support from Selvita's AI Team (kudos to Joerg Wichard and his Team). Whether you're already passionate about FBDD or just curious to learn more, I highly recommend attending the event and connecting with Aleksandra Bebel for a deeper dive into this fascinating field! #drugdiscovery #pharma #biotech #fragmentbased #medicinalchemistry #structuralbiology
Our colleagues are getting ready to participate in the 9th RSC-BMCS Fragment-based Drug Discovery Meeting in Cambridge, the UK! This will be an excellent opportunity to meet with our team: Alicja Małysiak, Aleksandra Bebel, Karol Źrubek, PhD and Alexander Ignatyev, and discover our vast portfolio of services that can support your drug discovery processes. If you would like to catch up with them, feel free to send us an e-mail at sales@selvita.com. #drugdiscovery #pharma #biotech #fragmentbased #medicinalchemistry #structuralbiology
-
-
Thoughts on this? >> AI biotechs Recursion and Exscientia first held deal talks in 2022 >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #productmarketing #healthcare #pharma #pharmaceutical
-
Please put on your agenda of booths that can materially impact your micronization operations in a very positive way at Interphex!
Join us at Interphex Javits Center, NYC on April 16-18, 2024 Our team is excited to be introducing the MP350 Microlyser™ Processor-an innovation in production scale cell disruption processing. Come by booth # 3421 and meet Steve Mesite, Director of Machines, and learn more about this revolutionary technology. "INTERPHEX, the leading global pharmaceutical and biotechnology event that fuses industry innovation with expert-led conference." #Interphex #Microfluidics #Microlysertechnology #Microlyserprocessor
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> AI biotechs Recursion and Exscientia first held deal talks in 2022 >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #healthcare #biotech #pharmaceutical
AI biotechs Recursion and Exscientia first held deal talks in 2022
endpts.com
-
📢 Attention, time change! May 16th, at 14:40, Stage 5 ✅ "From risk to remedy – Polish biotech's answers to sustain stable drug and diagnostics supply during shortages" 🎤 Join the discussion panel at Impact CEE, where Konstantin Matentzoglu (Polpharma Biologics) alongside Katarzyna Rolle (Polish Academy of Sciences), Dariusz Adamusiński (MedTech Poland), and moderator Joanna Bekker (Polityka Insight) will discuss how collaboration between businesses and science can strengthen supply chains when needed. Don't miss this important discussion! #IMPACTCEE #Innovation #Biotechnology #PolpharmaBiologics
-
-
More good things will happen as Biotech and Techbio come together
Lindus Health is honored to welcome Robert Langer, co-founder of Moderna and distinguished professor, to our advisory board! Dr. Langer has more than 1,400 patents issued and pending globally to 400+ companies in pharmaceuticals, chemicals, biotechnology, and medical devices. As a biotech pioneer of our time, his expertise will be instrumental in furthering our mission to bring innovative therapies to market and improve patient outcomes. Read the full press release here: https://lnkd.in/ePa4rwiV #healthcareinnovation #clinicaltrials #advisoryboard
-
-
🌍 World Pharma Today recently had the opportunity to interview Evotec, a pioneering biotechnology company, during the CPHI Milan event at #FieraMilano, #Italy. I'm thrilled to share insights from this conversation, highlighting Evotec's innovative contributions that are driving the future of biotech. Stay connected for more updates from this exciting event! #CPHIMilan #Evotec #Biotechnology #PharmaInnovation #FieraMilano #WorldPharmaToday
🌍 World Pharma Today had the privilege of interviewing Evotec, a leading global biotechnology company, at the prestigious CPHI Milan Event held at #FieraMilano, #Italy. During this insightful exchange, Evotec shared key advancements and innovative solutions driving the future of biotech. Stay tuned for more updates from this incredible event, where industry leaders are shaping the future of healthcare and pharmaceuticals. Email: kathryn@worldpharmatoday.com #CPHI #Evotec #Biotechnology #HealthcareInnovation #PharmaLeaders #WorldPharmaToday #CPHIMilan #PharmaIndustry #PharmaceuticalIndustry #CPHI2024 #WorldPharmaToday #PharmaIndustry
-
CEO at Albright Partners Executive Search I Boston I Copenhagen I London I Munich I Paris I Zürich I Stockholm
Interesting perspectives on navigating board roles in Pharma, MedTech & BioTech.
When it comes to the Life Sciences sector, the challenges faced by board members take on a whole new level of complexity. #boardsinlifesciences #pharma #medtech #biotech #boards #boardmember https://lnkd.in/dt_nM_uq
The Unique Challenges of Board Roles in Life Sciences
albrightglobal.com
